Glutamine, a central metabolic substrate in CRC, regulates mTORC1 activity indirectly by fueling LAT1-mediated leucine uptake via the ASCT2–LAT1 antiporter axis, highlighting its role as a metabolic gatekeeper. The gene discussed is SLC1A5; the disease is colorectal carcinoma.